Q. Platelet aggregation:
- is initiated at the site of an injury by conversion of fibrinogen to fibrin
- is inhibited in uninjured blood vessels by the secretion of prostacyclin by intact vascular endothelium
- causes morphological changes and a release of the vasodilator serotonine
- is inhibited by the release of ADP and thromboxane A2
Answer: is inhibited by the release of ADP and thromboxane A2
